In Brief: Endosonics
This article was originally published in The Gray Sheet
Executive Summary
Endosonics: Company's Cardiovascular Dynamics subsidiary receives 510(k) clearance for three Bullet Hi-Flo over-the-wire catheter models indicated for delivering therapeutic solutions in treatment of coronary disease. The three models, which utilize CVD's Multiple Microporous Membrane (M3) technology, provide "different flow rates and dosage regimens" of therapeutic agents to remote locations within the heart's arteries. The Bullet catheter received FDA clearance in the fourth quarter of 1994 for peripheral vascular applications ("The Gray Sheet" Oct. 24, 1994, In Brief)...